Sign In
Buy BMRN
$54.66
+1.34 (+2.51%)
At Close: Jun 03, 2026
BioMarin Announces Legal Action Against Ascendis Pharma A/S in European Unified Patent Court
12:00pm, Monday, 13'th Jan 2025
SAN RAFAEL, Calif. , Jan. 13, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the company has initiated a legal action against Ascendis Pharma A/S for infringemen
Wall Street Analysts Predict a 45.86% Upside in BioMarin (BMRN): Here's What You Should Know
10:55am, Monday, 13'th Jan 2025
The consensus price target hints at a 45.9% upside potential for BioMarin (BMRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
10:46am, Monday, 13'th Jan 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
10:46am, Thursday, 09'th Jan 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 4 Stocks Boast Impressive Interest Coverage Ratios
11:35am, Monday, 06'th Jan 2025
LDOS, AMZN, HALO & BMRN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
SAN RAFAEL, Calif. , Jan. 6, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at t
10 Magnificent Stocks That Can Make You Richer in 2025
05:06am, Friday, 03'rd Jan 2025
For a second straight year, investors have been given every reason to smile. As of this writing, with one trading day left in 2024, the iconic Dow Jones Industrial Average, benchmark S&P 500, and grow
3 Reasons Why Growth Investors Shouldn't Overlook BioMarin (BMRN)
01:54pm, Thursday, 02'nd Jan 2025
BioMarin (BMRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
BMRN or TECH: Which Is the Better Value Stock Right Now?
12:46pm, Thursday, 02'nd Jan 2025
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Techne (TECH). But which of these two stocks presents inves
Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
10:40am, Thursday, 26'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
10:45am, Tuesday, 24'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical (BMRN) Stock?
09:40am, Thursday, 19'th Dec 2024
Investors need to pay close attention to BioMarin Pharmaceutical (BMRN) stock based on the movements in the options market lately.
BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
10:50am, Wednesday, 11'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is BioMarin (BMRN) Down 1.9% Since Last Earnings Report?
12:36pm, Thursday, 28'th Nov 2024
BioMarin (BMRN) reported earnings 30 days ago. What's next for the stock?
Can BioMarin Stock Live Up to Wall Street's High Expectations?
07:01am, Friday, 22'nd Nov 2024
BioMarin Pharmaceutical NASDAQ: BMRN has been a rough investment for a long time. Over the past 10 years, shares have provided a total return of -28%.
